Dyno Nobel (ASX:DNL): Explosives Earnings, Fertilisers Exit and FY26 Outlook

Aditi Sarkar

23 October 2026 04:59 PM AEDT

Dyno Nobel (ASX:DNL): Explosives Earnings, Fertilisers Exit and FY26 Outlook

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Dyno Nobel (ASX:DNL) recorded 1H26 EBIT excluding material items of AUD 243 million.
Half-year net profit excluding material items reached AUD 161 million, compared with AUD 88 million.
The company completed the Phosphate Hill sale in June 2026, exiting fertilisers manufacturing.
Dyno Nobel unveiled an autonomous blast-hole inspection and loading prototype in September 2026.

Dyno Nobel Limited manufactures commercial explosives and provides blasting technology and services to mining and quarrying customers across Australia and international markets. At the time of writing on 23 October 2026, Dyno Nobel (ASX:DNL) was quoted at AUD 3.87, down 1.28% for the trading session. Its 2026 developments include half-year earnings from explosives operations, the completed exit from fertilisers manufacturing and a newly presented autonomous blasting system.

Company Business

Dyno Nobel (ASX:DNL) supplies bulk and packaged explosives, initiating systems and related technical services for extracting minerals and other materials. Its operations are reported through Dyno Nobel Asia Pacific (DNAP), Dyno Nobel Americas (DNA) and Dyno Nobel EMEA & LATAM (DNEL), covering Europe, the Middle East, Africa and Latin America.

The business combines explosives manufacturing with site-based blast planning, delivery and technology. Its customers include mining operations working in metals, coal and other resource segments. Manufacturing inputs, distribution networks and the timing of mining activity therefore influence operating requirements across different regions.

Recent Development

In September 2026, Dyno Nobel (ASX:DNL) presented a prototype autonomous bench system designed to inspect blast holes and load initiating systems and bulk explosives without placing operators directly on the blast bench. The company stated that the fully built prototype would undergo trials at a mine in Utah. The system remains at a testing stage rather than a source of reported earnings.

In July 2026, the company confirmed that its Phosphate Hill fertilisers manufacturing business had been sold, with completion occurring on 30 June. Transaction terms included a fixed AUD 50 million completion payment by Dyno Nobel, deferred consideration of AUD 150 million subject to conditions and AUD 125.9 million of funding for future rehabilitation and remediation obligations.

That transaction followed the wider separation of its fertilisers activities, allowing the group to concentrate its operating portfolio on commercial explosives. Future financial reporting will distinguish continuing explosives operations from discontinued fertilisers activities.

Financial Performance and Sector Context

For the six months ended 31 March 2026, Dyno Nobel (ASX:DNL) reported statutory net profit after tax of AUD 20 million, compared with AUD 7 million a year earlier. Net profit excluding individually material items rose to AUD 161 million from AUD 88 million. The distinction matters because statutory earnings included AUD 141 million of after-tax material items, mainly associated with Phosphate Hill impairment and exit costs.

Group EBIT excluding individually material items reached AUD 243 million, up 39% from AUD 174 million in 1H25. EBITDA on the same basis increased 17% to AUD 378 million from AUD 323 million. Continuing-operations revenue rose 9% to AUD 1,609.8 million, while total reported revenue fell 16% to AUD 1,897.8 million amid the business separation.

The regional mix varied. DNAP reported EBIT of AUD 130 million, up 16%, and DNA recorded AUD 101 million, up 42%. DNEL reported AUD 9 million, down 29%, with prior-period disposal gains and currency effects influencing the comparison. These figures reflect differences in customer demand, product mix and local operating conditions.

At its May half-year announcement, Dyno Nobel reaffirmed FY26 explosives EBIT guidance of approximately AUD 460 million to AUD 500 million and a FY28 EBIT ambition of AUD 600 million. The FY26 full-year results were scheduled for 9 November 2026, so final FY26 earnings had not yet been published as of 23 October.

Risks to Consider

Dyno Nobel (ASX:DNL) is exposed to mining customer activity, industrial input costs, foreign-exchange movements, manufacturing outages and operating safety risks. Its total recordable injury frequency rate for the 12 months ended March 2026 increased to 1.22 from 0.92 at September 2025. The autonomous system requires field testing, while remaining Phosphate Hill payments and obligations depend on transaction terms and performance conditions.

What to Watch Next

For Dyno Nobel (ASX:DNL), the next scheduled milestone is the 9 November 2026 full-year results announcement. Relevant measures include FY26 explosives EBIT against guidance, regional earnings, cash flow, progress on the company’s transformation initiatives and updates on share repurchases. Field-trial outcomes for the autonomous bench prototype and the integration of operational changes will also provide evidence of progress.

Key Insights

Dyno Nobel reported higher half-year earnings excluding material items and completed the transfer of Phosphate Hill in June. For Dyno Nobel (ASX:DNL), the FY26 results, continuing regional performance and testing of new blasting technology are the next identifiable reporting and operational milestones.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.